SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000819050-20-000060
Filing Date
2020-04-03
Accepted
2020-04-03 16:23:29
Documents
1
Effectiveness Date
2020-04-03

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxy04032020defa-14a.htm DEFA14A 31718
  Complete submission text file 0000819050-20-000060.txt   32839
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21088 | Film No.: 20773664
SIC: 2836 Biological Products, (No Diagnostic Substances)